Press Releases Mountain Valley MD Holdings Inc. Börse Stuttgart

Equities

20MP

CA62430M1014

Delayed Börse Stuttgart Other stock markets 11:33:05 14/05/2024 am IST			5-day change	1st Jan Change
0.0342 ^EUR	+11.04%		-9.94%	+77.01%

01/03	Mountain Valley MD Holdings Inc. Plans to Introduce Soluvec 1% Coated Fish Feed in Bangladesh by May of 2024	CI
01/03	Mountain Valley MD Holdings Inc. Provides Update on Agrarius Trial Results	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mountain Valley MD Announces Acquisition of Exclusive License for Agrarius, Launch of Performance Guarantee Program	24/04	BU
Mountain Valley MD Announces Stock Option Grant	08/04	BU
Mountain Valley MD Provides Business Update, Appoints New CFO	01/03	BU
Mountain Valley MD Announces Planned Appointment of New CFO Effective January 15, 2024	16/12	BU
Mountain Valley MD Announces Appointment of New CFO	08/23/08	BU
Mountain Valley MD Provides Business Update	11/23/11	BU
Mountain Valley MD Announces Publication of Soluvec™ Trial Data in Therapeutic Delivery	10/23/10	BU
Mountain Valley MD Executes Soluvec™ 1% License Agreement, Expands Patent Protection	08/23/08	GL
Mountain Valley MD Announces Stock Option Grant	07/23/07	GL
Mountain Valley MD Announces Transition of Chief Medical Officer to Advisory Role	12/23/12	GL
Mountain Valley MD Provides Notice of Redemption for Class “B” Non-Voting Shares. Common Shares Trading on CSE Unaffected	08/22/08	GL
Mountain Valley MD Provides Notice of Redemption for Class “B” Non-Voting Shares. Common Shares Trading on CSE Unaffected	08/22/08	AQ
Mountain Valley MD Provides Business Update, Focus On Commercialization Phase	29/22/29	GL
Mountain Valley MD Provides Business Update, Focus On Commercialization Phase	29/22/29	AQ
Mountain Valley MD Commences Commercial Sales of Agrarius, an Agro Plant Technology	13/22/13	GL
Mountain Valley MD Commences Commercial Sales of Agrarius, an Agro Plant Technology	13/22/13	AQ
Mountain Valley MD : Q1 Financial Statements	26/22/26	PU
Mountain Valley MD : Q1 Management Discussion and Analysis	26/22/26	PU
Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1%	27/22/27	GL
Mountain Valley MD Successfully Completes Pre-Clinical Pharmacokinetic Study For Soluvec™1%	27/22/27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Mountain Valley MD Holdings Inc. Börse Stuttgart

Equities

20MP

CA62430M1014

Press Releases

Filters